A study was done to evaluate the two polymorphisms of BAX (-248 G>A) and BCL2 (-838C>A) in promoter regions, as well as the functional polymorphism of TP53 (Arg72Pro) and their associations with the risk of SCCHN in a US non-Hispanic white population. The gene discussed is BCL2; the disease is head and neck squamous cell carcinoma.